A Mixture Transition Distribution Modeling for Higher‐Order Circular Markov Processes
Journal of Time Series Analysis · 2026-03 · 47 (2) · 304-320
DOI: 10.1111/jtsa.12803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Time Series Analysis, online erschienen am 10.12.2024. Verfasst von Hiroaki Ogata und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
This study considers the stationary higher‐order Markov process for circular data by employing the mixture transition distribution modeling. The underlying circular transition distribution is based on Wehrly and Johnson's bivariate joint circular models. The structures of the circular autocorrelation function, together with the circular partial autocorrelation function, are investigated. They are found to be similar to those of the autocorrelation and partial autocorrelation functions of the real‐valued autoregressive process when the underlying binding density has zero sine moments. The validity of the model is assessed by applying it to some Monte Carlo simulations and real directional data.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Ogata, H., & Shiohama, T. (2026). A Mixture Transition Distribution Modeling for Higher‐Order Circular Markov Processes. Journal of Time Series Analysis, 47(2), 304-320. https://doi.org/10.1111/jtsa.12803
Vancouver
Ogata H, Shiohama T. A Mixture Transition Distribution Modeling for Higher‐Order Circular Markov Processes. Journal of Time Series Analysis. 2026;47(2):304-320. doi:10.1111/jtsa.12803
BibTeX
@article{Ogata2026,
author = {Ogata, Hiroaki and Shiohama, Takayuki},
title = {A Mixture Transition Distribution Modeling for Higher‐Order Circular Markov Processes},
journal = {Journal of Time Series Analysis},
year = {2026},
volume = {47},
number = {2},
pages = {304--320},
doi = {10.1111/jtsa.12803}
}
EUVIMED